A novel APOC2 mutation in a Colombian patient with recurrent hypertriglyceridemic pancreatitis

  • Gabriel D. Pinilla-Monsalve
  • , Juliana Lores
  • , Harry Pachajoa
  • , Juan D.López Ponce de León
  • , Alejandro López
  • , Lisa X. Rodríguez-Rojas
  • , José A. Nastasi-Catanese

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis.

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalApplication of Clinical Genetics
Volume13
DOIs
StatePublished - 2020
Externally publishedYes

Keywords

  • Apolipoprotein C-II
  • Hyperlipoproteinemia type I
  • Hypertriglyceridemia
  • Pancreatitis

Fingerprint

Dive into the research topics of 'A novel APOC2 mutation in a Colombian patient with recurrent hypertriglyceridemic pancreatitis'. Together they form a unique fingerprint.

Cite this